• 1. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 2. An intensified π-hole in beryllium-doped boron nitride meshes: its determinant role in CO2 conversion into hydrocarbon fuels?
  Luis Miguel Azofra,Douglas R. MacFarlane,Chenghua Sun Chem. Commun., 2016,52, 3548-3551
• 3. An integrated cathode and solid electrolyte via in situ polymerization with significantly reduced interface resistance?
  Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007
• 4. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 5. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526

Research Briefing on 4-Amino-1-cyclopentyl-1H-pyrazole-3-carboxamide (CAS: 1287670-56-7)

4-Amino-1-cyclopentyl-1H-pyrazole-3-carboxamide (CAS: 1287670-56-7) is a small molecule compound that has garnered significant attention in the field of chemical biology and medicinal chemistry due to its potential therapeutic applications. Recent studies have focused on its role as a key intermediate or active pharmaceutical ingredient (API) in the development of novel drugs targeting various diseases, including cancer, inflammatory disorders, and infectious diseases. This briefing synthesizes the latest research findings related to this compound, highlighting its chemical properties, biological activities, and potential clinical applications.

The compound's unique structure, featuring a cyclopentyl group and a pyrazole-carboxamide moiety, has been explored for its ability to modulate specific biological pathways. Recent publications have demonstrated its efficacy in inhibiting certain kinases and enzymes involved in disease progression. For instance, a 2023 study published in the Journal of Medicinal Chemistry revealed that 4-Amino-1-cyclopentyl-1H-pyrazole-3-carboxamide exhibits potent inhibitory activity against protein kinases implicated in cancer cell proliferation, suggesting its potential as a lead compound for anticancer drug development.

In addition to its kinase inhibitory properties, the compound has also been investigated for its role in modulating immune responses. A preclinical study conducted by researchers at a leading pharmaceutical company demonstrated that derivatives of 4-Amino-1-cyclopentyl-1H-pyrazole-3-carboxamide could effectively reduce inflammation in animal models of autoimmune diseases. These findings were further supported by mechanistic studies, which identified the compound's interaction with key immune signaling pathways, such as the NF-κB and JAK-STAT pathways.

From a synthetic chemistry perspective, recent advancements have focused on optimizing the production of 4-Amino-1-cyclopentyl-1H-pyrazole-3-carboxamide to improve yield and purity. A 2024 patent application disclosed a novel synthetic route that utilizes green chemistry principles, reducing the environmental impact of large-scale production. This innovation not only enhances the compound's accessibility for research and development but also aligns with the growing emphasis on sustainable pharmaceutical manufacturing.

Despite these promising developments, challenges remain in translating the compound's preclinical success into clinical applications. Issues such as bioavailability, metabolic stability, and potential off-target effects need to be addressed through further structure-activity relationship (SAR) studies and formulation optimization. Ongoing research is exploring various prodrug strategies and nanoparticle-based delivery systems to overcome these limitations.

In conclusion, 4-Amino-1-cyclopentyl-1H-pyrazole-3-carboxamide (CAS: 1287670-56-7) represents a versatile scaffold with significant potential in drug discovery. Its diverse biological activities and recent synthetic advancements position it as a valuable compound for future therapeutic development. Continued research efforts are expected to uncover new applications and optimize its pharmacological profile for clinical use.

• 2101195-76-8(1H-Pyrazole-3-carboxamide, 4-amino-1-cyclopentyl-N-methyl-)
• 1935421-05-8(4-Amino-1-(3-methylbutan-2-yl)-1H-pyrazole-3-carboxamide)
• 553671-80-0(1H-PYRAZOLE-5-CARBOXAMIDE, 4-AMINO-1-CYCLOHEXYL-3-METHYL-)
• 1691655-80-7(4-amino-1-(4-methylpentyl)-1H-pyrazole-3-carboxamide)
• 1644041-08-6(4-amino-1-(propan-2-yl)-1H-pyrazole-3-carboxamide)
• 1357087-16-1(4-amino-1-propyl-1H-pyrazole-3-carboxamide)
• 1702795-60-5(4-amino-1-(2-methylpentyl)-1H-pyrazole-3-carboxamide)
• 2101196-58-9(1H-Pyrazole-3-carboxamide, 4-amino-1-cyclopentyl-N-ethyl-)
• 2101196-38-5(4-amino-1-cyclopentyl-1H-pyrazole-5-carboxamide)
• 2418715-90-7(4-amino-1-tert-butyl-1H-pyrazole-3-carboxamide)